1. Home
  2. TDAY vs PHAT Comparison

TDAY vs PHAT Comparison

Compare TDAY & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TDAY

USA TODAY Co. Inc.

HOLD

Current Price

$7.06

Market Cap

1.1B

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$9.40

Market Cap

969.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDAY
PHAT
Founded
2013
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
969.8M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
TDAY
PHAT
Price
$7.06
$9.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$9.00
$19.83
AVG Volume (30 Days)
2.3M
1.6M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
105.56
42.72
EPS
0.18
N/A
Revenue
$1,526,024,000.00
$175,110,000.00
Revenue This Year
N/A
$93.04
Revenue Next Year
N/A
$58.91
P/E Ratio
$38.00
N/A
Revenue Growth
N/A
216.93
52 Week Low
$4.54
$8.21
52 Week High
$9.21
$18.31

Technical Indicators

Market Signals
Indicator
TDAY
PHAT
Relative Strength Index (RSI) 33.14 45.21
Support Level $6.52 $8.50
Resistance Level $7.48 $11.85
Average True Range (ATR) 0.49 0.62
MACD -0.20 -0.01
Stochastic Oscillator 18.27 30.27

Price Performance

Historical Comparison
TDAY
PHAT

About TDAY USA TODAY Co. Inc.

USA Today Co Inc is a diversified media company with national and local reach, dedicated to empowering and enriching communities. It prioritizes a digital-first approach, focusing on audience growth and engagement while diversifying revenue streams. Through its trusted brands, including the USA TODAY NETWORK, comprised of the national publication, USA TODAY, and local media organizations, including a network of local properties, in the United States, and Newsquest, a wholly-owned subsidiary operating in the United Kingdom, provide essential journalism, local content, and digital experiences to audiences and businesses. Its digital marketing solutions brand, LocaliQ, supports small and medium-sized businesses with digital marketing products and solutions.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: